trending Market Intelligence /marketintelligence/en/news-insights/trending/zWDaO0wfEW1ptZDeLHIUGg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

CymaBay plans common stock offering

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


CymaBay plans common stock offering

CymaBay Therapeutics Inc. plans to sell its common stock in an underwritten public offering.

The company intends to use the proceeds of the offering to fund ongoing development of seladelpar and for working capital and general corporate purposes.

JonesTrading Institutional Services LLC is acting as the sole book-running manager, with LifeSci Capital LLC as the lead manager for the offering.